These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17527051)

  • 1. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report.
    Makino K; Nakamura H; Kudo M; Takeshima H; Kuratsu J
    Neurol Med Chir (Tokyo); 2007 May; 47(5):229-32. PubMed ID: 17527051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.
    Lerro KA; Lacy J
    J Neurooncol; 2002 Sep; 59(2):165-8. PubMed ID: 12241110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
    Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
    Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
    Reni M; Ferreri AJ; Landoni C; Villa E
    J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
    Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
    Wong ET; Tishler R; Barron L; Wu JK
    Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.
    Wong SF; Gan HK; Cher L
    J Clin Neurosci; 2012 Nov; 19(11):1501-5. PubMed ID: 22995759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response following adjuvant Temozolomide in a patient with primary cerebral lymphoma.
    Strik HM; Spreer A; Nagel H; Jacob S; Jung W; Kitze B; Bähr M
    Anticancer Res; 2004; 24(6):4121-5. PubMed ID: 15736462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma.
    Aksoy S; Abali H; Kiliçkap S; Güler N
    J Neurooncol; 2005 Feb; 71(3):333-4. PubMed ID: 15735926
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma.
    Paul MJ; Summers Y; Calvert AH; Rustin G; Brampton MH; Thatcher N; Middleton MR
    Melanoma Res; 2002 Apr; 12(2):175-8. PubMed ID: 11930115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2004 May; 11(4):374-5. PubMed ID: 15080950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide.
    Pitini V; Baldari S; Altavilla G; Arrigo C; Naro C; Perniciaro F
    J Neurooncol; 2007 Jul; 83(3):291-3. PubMed ID: 17245621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to temozolomide in second-line treatment of recurrent nonsmall cell lung carcinoma: case report.
    Somer RA; Langer CJ
    Cancer Invest; 2005; 23(2):134-7. PubMed ID: 15813506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.
    Rehman S; Brock C; Newlands ES
    Am J Clin Oncol; 2006 Feb; 29(1):106-7. PubMed ID: 16462515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide as salvage treatment in primary brain lymphomas.
    Reni M; Zaja F; Mason W; Perry J; Mazza E; Spina M; Bordonaro R; Ilariucci F; Faedi M; Corazzelli G; Manno P; Franceschi E; Pace A; Candela M; Abbadessa A; Stelitano C; Latte G; Ferreri AJ
    Br J Cancer; 2007 Mar; 96(6):864-7. PubMed ID: 17325700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival over 6 years in a patient with brain metastases from melanoma treated with temozolomide.
    Koekkoek JA; Wiggenraad RG; Zwinkels H; Oosterkamp HM; Taphoorn MJ
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23008380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.